Þögli faraldurinn – sýklalyfjaónæmi

dc.contributor.author	Kristinsson, Karl Gústaf
dc.contributor.department	Læknadeild
dc.date.accessioned	2025-11-20T08:51:43Z
dc.date.available	2025-11-20T08:51:43Z
dc.date.issued	2022-03-03
dc.format.extent	1
dc.format.extent	682679
dc.format.extent	119
dc.identifier.citation	Kristinsson, K G 2022, 'Þögli faraldurinn – sýklalyfjaónæmi', Læknablaðið, vol. 108, no. 3, pp. 119. https://doi.org/10.17992/lbl.2022.03.678	en
dc.identifier.doi	10.17992/lbl.2022.03.678
dc.identifier.issn	1670-4959
dc.identifier.other	62659323
dc.identifier.other	4461731e-9985-40bd-8a7a-59d401349cbc
dc.identifier.other	35230255
dc.identifier.other	85125552693
dc.identifier.other	unpaywall: 10.17992/lbl.2022.03.678
dc.identifier.uri	https://hdl.handle.net/20.500.11815/6818
dc.language.iso	is
dc.relation.ispartofseries	Læknablaðið; 108(3)	en
dc.relation.url	https://www.scopus.com/pages/publications/85125552693	en
dc.rights	info:eu-repo/semantics/openAccess	en
dc.subject	Anti-Bacterial Agents/adverse effects	en
dc.subject	COVID-19	en
dc.subject	Drug Resistance, Bacterial	en
dc.subject	Humans	en
dc.subject	Pandemics	en
dc.subject	SARS-CoV-2	en
dc.subject	Drug Resistance, Microbial	en
dc.subject	General Medicine	en
dc.title	Þögli faraldurinn – sýklalyfjaónæmi	is
dc.title.alternative	The silent pandemic - antimicrobial resistance	en
dc.type	/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/editorial	en

Skrár

Niðurstöður 1 - 1 af 1